Fetal echocardiography efficiency. Clinical experience;Eficacia de la ecocardiografía fetal. Experiencia clínica

Ginecologia y Obstetricia de Mexico

Volumn 76, Issue 12, 2008, Pages 706-716

  Miranda, Raúl San Luis ^a,c,d   Monroy, Laura Guadalupe Arias ^b   González, Gladis Alicia Gutiérrez ^b   Ávila, José Luis León ^b   Rodríguez, Armando Cruz ^b   Correa, Porfirio Rafael Osornio ^b  

^a Servicio de Hemodinámica

^b Servicio de Perinatología Medicina Materno Fetal

^c NONE   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Fetal cardiology; Fetal echocardiography; Prenatal diagnosis

Indexed keywords

ADULT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RISK; CONGENITAL HEART DISEASE; DIAGNOSTIC ACCURACY; EBSTEIN ANOMALY; ECHOCARDIOGRAPHY; FETUS; FETUS ECHOGRAPHY; GESTATIONAL AGE; HEART TUMOR; HIGH RISK PREGNANCY; HUMAN; HYDRAMNIOS; HYPOPLASTIC LEFT HEART SYNDROME; MAJOR CLINICAL STUDY; MATERNAL AGE; OLIGOHYDRAMNIOS; PREDICTION AND FORECASTING; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PROGNOSIS; RISK FACTOR; TERATOLOGY; UNIQUE VENTRICLE;

ADULT; DATA INTERPRETATION, STATISTICAL; ECHOCARDIOGRAPHY; FEMALE; FETAL HEART; GESTATIONAL AGE; HEART DEFECTS, CONGENITAL; HUMANS; MATERNAL AGE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY, HIGH-RISK; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 57449114540     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cullen S, Sharland G, Allan L, Sullivan I. Potential impact of population screening for prenatal diagnosis heart disease. Arch Dis Chil 1992;67:775-7.
2. Zimmer EZ, Avraham Z, Sujoy P, Goldstein I, Bronshtein M. The influence of prenatal ultrasound on the prevalence of congenital anomalies at birth. Prenat Diagn 1997;17:623-8.
3. Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol 1978;42(4):641-7.
4. st ed. Stanford: Appleton and Lange, 1999.
5. Hoffman J. Incidence of congenital heart disease: I postnatal incidence. Pediatr Cardiol 1995;16:103-13.
6. Allan LD, Crawford DC, Chita SK, Anderson RH, Tynan MJ. Familial recurrence of congenital heart disease in a prospective series of mother referred for fetal echocardiography. Am J Cardiol 1988;58;334-7.
7. Hinojosa CJ, San Luis MR, Veloz MMG, Puello TE y col. Diagnóstico y frecuencia de cardiopatía fetal mediante ecocardiografía en embarazos con factores de alto riesgo. Ginecol Obstet Mex 2006;74(12):645-56.
8. Quiroz VL, Siebald CE, Belmar JC, Urcelay MG, Carvajal CJ. El diagnóstico prenatal de cardiopatías congénitas mejora el pronóstico neonatal. Rev Chil Obstet Ginecol 2006;71(4):267-3.
9. Comstock C. What to expect from routine mid-trimester screening for congenital heart disease. Semin Perinatol 2000;24:331-42.
10. Gembruch U. Prenatal diagnosis of congenital heart disease. Prenat Diagn 1997;17:1283-97.
11. Allan LD, Sharland GK, Milburn A, Lockhart SM, et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 1994;23:1452-8.
12. Kovalchin JP, Silverman NH. The impact of fetal echocardiography. Pediatr Cardiol 2004;25(3):299-306.
13. Crane JP, LeFevre ML, Winborn RC, Evans JK, et al. RADIUS Study Group. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. Am J Obstet Gynecol 1994;171:392-9.
14. Fernandez CO, Ramaciotti C, Martin LB, Twickler DM. The four-chamber view and its sensitivity in detecting congenital heart defects. Cardiology 1998;90:202-6.
15. González GR. Ecocardiografía fetal ¿cómo mejorar nuestra capacidad diagnóstica? Rev Chil Obstet Ginecol 2005;70(3):140-6.
16. Yagel S, Cohen SM, Messing B. First and early second trimester fetal heart screening. Curr Opin Obstet Gynecol 2007;19:183-90.
17. Wong SF, Chan FY, Cincotta RB, Lee-Tannock A, Ward C. Factors influencing the prenatal detection of structural congenital heart diseases. Ultrasound Obstet Gynecol 2003;21:19-25.
18. Huggon IC, Ghi T, Cook AC, Zosmer N, et al. Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol 2002;20:22-29.
19. Ott WJ. The accuracy of antenatal fetal echocardiography screening in high- and low- risk patients. Am J Obstet Gynecol 1995;172(6):1741-7.
20. Benacerraf BR, Pober BR, Sanders SP. Accuracy of fetal echocardiography. Radiology 1987;165(3):847-9.
21. nd ed. London: Greenwich Medical Media, 2000.
22. Rychik J, Ayres N, Cuneao B, Gotteiner N, et al. American Society of Echocardiography Guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr 2004;17(7):803-10.
23. Viñals F, Giuliano A. Cardiopatías congénitas. Incidencia antenatal. Rev Chil Obste Ginecol 2002;67(3):203-6.
24. Forbus GA, Atz AM, Shirali GS. Implications and limitations of an abnormal fetal echocardiogram. Am J Cardiol 2004;94:688-9.
25. Todros T, Faggiano F, Chiappa E, Gaglioti P, et al. Accuracy of routine ultrasonography in screening heart disease prenatally. Gruppo Piemontese for Prenatal Screening of Congenital Heart Disease. Prenat Diagn 1997;17:901-6.
26. Mohan UR, Kleinman ChS, Kern JH. Fetal echocardiography and its involving impact 1992 a 2002. Am J Cardiol 2005;96:134-6.
27. Klein SK, Cans C, Robert E, Jouk PS. Efficacy of routine ultrasound screening for congenital heart disease in Isere County, France. Prenat Diagn 1999;19:318-22.
28. Hafner E, Scholler J, Schucter K, Sterniste W, Philipp K, et al. Detection of fetal congenital heart disease in a low-risk population. Prenat Diagn 1998;8:808-15.
29. Ogge G, Gaglioti P, Maccanti S, FaggianoF, Todros T. Prenatal screening for congenital heart disease with four-chamber and outflow-tract views: a multicenter study. Ultrasound Obstet Gynecol 2006;28:779-84.
30. Yoo SJ, Lee YH, Kim ES, Ryu HM, et al. Tree-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol 1997;9:173-83.
31. Simpson LL, Malone FD, Bianchi DW, Ball RH, et al. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol 2007;109(2):376-83.
32. Allan LD. The outcome of fetal congenital heart disease. Semin Perinatol 2000;24(5):380-4.
33. DeVore GR. The role of fetal echocardiography. Semin Perinatal 2000;327(2):160-72.
34. Bhat AH, Sahn DJ. Latest advances and topics in fetal echocardiography. Curr Opin Cardiol 2004;19:97-103.
35. Rahmi BA, Arun OE, Kanik A, Kanitn H, Nur AF. Accuracy of prenatal diagnosis of congenital heart disease with fetal echocardiography. Fetal Diagn Ther 2007;22:241-4.
36. Stoll C, Dott B, Alembik Y, De Geeter B. Evaluation and evolution during time of prenatal diagnosis of congenital heart diseases by routine fetal ultrasonographic examination. Ann Genet 2002;45:21-27.
37. Sandor GG, Farquarson D, Wittmann B, Chow TC, Lau AE. Fetal echocardiography: results in high-risk patients. Obstet Gynecol 1986;67(3):358-64.
38. Sullivan ID. Prenatal diagnosis of structural heart disease: does it make a difference to survival? Arch Dis Child Fetal Neonatal 2002;87;19-20.
39. Bonnet D, Coltri A, Butera G, Fermont L, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999;99:916-8.